nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—Rosuvastatin—atherosclerosis	0.102	0.211	CbGbCtD
Budesonide—CYP3A4—Ezetimibe—atherosclerosis	0.102	0.211	CbGbCtD
Budesonide—CYP3A4—Simvastatin—atherosclerosis	0.0953	0.196	CbGbCtD
Budesonide—CYP3A4—Lovastatin—atherosclerosis	0.0932	0.192	CbGbCtD
Budesonide—CYP3A4—Pravastatin—atherosclerosis	0.0932	0.192	CbGbCtD
Budesonide—CYP3A4—Irinotecan Pathway—NPC1—atherosclerosis	0.0035	0.0638	CbGpPWpGaD
Budesonide—Betamethasone—PLA2G1B—atherosclerosis	0.00256	0.43	CrCbGaD
Budesonide—CYP3A4—Liver X Receptor Pathway—ABCG8—atherosclerosis	0.0024	0.0439	CbGpPWpGaD
Budesonide—CYP3A4—Liver X Receptor Pathway—CYP7A1—atherosclerosis	0.00172	0.0314	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—atherosclerosis	0.00151	0.0276	CbGpPWpGaD
Budesonide—Dexamethasone—PLA2G1B—atherosclerosis	0.00149	0.25	CrCbGaD
Budesonide—CYP3A4—Liver X Receptor Pathway—ABCG5—atherosclerosis	0.00149	0.0272	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—atherosclerosis	0.00122	0.0223	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—atherosclerosis	0.00116	0.0211	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—FABP4—atherosclerosis	0.00114	0.0208	CbGpPWpGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.00113	0.0206	CbGpPWpGaD
Budesonide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00104	0.00229	CcSEcCtD
Budesonide—Muscle spasms—Ezetimibe—atherosclerosis	0.00104	0.00229	CcSEcCtD
Budesonide—Vision blurred—Lovastatin—atherosclerosis	0.00104	0.00229	CcSEcCtD
Budesonide—Mental disorder—Simvastatin—atherosclerosis	0.00103	0.00229	CcSEcCtD
Budesonide—CYP3A4—Farnesoid X Receptor  Pathway—CYP7A1—atherosclerosis	0.00103	0.0188	CbGpPWpGaD
Budesonide—Tremor—Lovastatin—atherosclerosis	0.00103	0.00227	CcSEcCtD
Budesonide—Visual impairment—Pravastatin—atherosclerosis	0.00103	0.00227	CcSEcCtD
Budesonide—Ill-defined disorder—Lovastatin—atherosclerosis	0.00102	0.00225	CcSEcCtD
Budesonide—Eye disorder—Niacin—atherosclerosis	0.00101	0.00224	CcSEcCtD
Budesonide—Flatulence—Simvastatin—atherosclerosis	0.00101	0.00224	CcSEcCtD
Budesonide—Dysgeusia—Simvastatin—atherosclerosis	0.00101	0.00222	CcSEcCtD
Budesonide—Flushing—Niacin—atherosclerosis	0.00101	0.00222	CcSEcCtD
Budesonide—Angioedema—Lovastatin—atherosclerosis	0.001	0.00222	CcSEcCtD
Budesonide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.001	0.00221	CcSEcCtD
Budesonide—Anaemia—Ezetimibe—atherosclerosis	0.000996	0.0022	CcSEcCtD
Budesonide—Malaise—Lovastatin—atherosclerosis	0.000991	0.00219	CcSEcCtD
Budesonide—Cardiac disorder—Pravastatin—atherosclerosis	0.000991	0.00219	CcSEcCtD
Budesonide—Flushing—Pravastatin—atherosclerosis	0.000991	0.00219	CcSEcCtD
Budesonide—Muscle spasms—Simvastatin—atherosclerosis	0.000988	0.00218	CcSEcCtD
Budesonide—Vertigo—Lovastatin—atherosclerosis	0.000987	0.00218	CcSEcCtD
Budesonide—Angioedema—Ezetimibe—atherosclerosis	0.000985	0.00218	CcSEcCtD
Budesonide—Angiopathy—Niacin—atherosclerosis	0.000984	0.00217	CcSEcCtD
Budesonide—Malaise—Ezetimibe—atherosclerosis	0.000972	0.00215	CcSEcCtD
Budesonide—Vision blurred—Simvastatin—atherosclerosis	0.000969	0.00214	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000964	0.00213	CcSEcCtD
Budesonide—Tremor—Simvastatin—atherosclerosis	0.000963	0.00213	CcSEcCtD
Budesonide—Alopecia—Niacin—atherosclerosis	0.000958	0.00212	CcSEcCtD
Budesonide—Insomnia—Rosuvastatin—atherosclerosis	0.000957	0.00211	CcSEcCtD
Budesonide—NR3C1—Nuclear Receptors—ESR2—atherosclerosis	0.000957	0.0175	CbGpPWpGaD
Budesonide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000954	0.00211	CcSEcCtD
Budesonide—Palpitations—Ezetimibe—atherosclerosis	0.000952	0.0021	CcSEcCtD
Budesonide—Paraesthesia—Rosuvastatin—atherosclerosis	0.00095	0.0021	CcSEcCtD
Budesonide—Anaemia—Simvastatin—atherosclerosis	0.00095	0.0021	CcSEcCtD
Budesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.000946	0.0173	CbGpPWpGaD
Budesonide—Malnutrition—Niacin—atherosclerosis	0.000944	0.00209	CcSEcCtD
Budesonide—Alopecia—Pravastatin—atherosclerosis	0.000943	0.00208	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—atherosclerosis	0.000941	0.0172	CbGpPWpGaD
Budesonide—Cough—Ezetimibe—atherosclerosis	0.00094	0.00208	CcSEcCtD
Budesonide—Angioedema—Simvastatin—atherosclerosis	0.000939	0.00208	CcSEcCtD
Budesonide—Chest pain—Lovastatin—atherosclerosis	0.000935	0.00207	CcSEcCtD
Budesonide—Myalgia—Lovastatin—atherosclerosis	0.000935	0.00207	CcSEcCtD
Budesonide—Arthralgia—Lovastatin—atherosclerosis	0.000935	0.00207	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—RETN—atherosclerosis	0.000933	0.017	CbGpPWpGaD
Budesonide—Anxiety—Lovastatin—atherosclerosis	0.000932	0.00206	CcSEcCtD
Budesonide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000931	0.00206	CcSEcCtD
Budesonide—Hypertension—Ezetimibe—atherosclerosis	0.00093	0.00206	CcSEcCtD
Budesonide—Flatulence—Niacin—atherosclerosis	0.00093	0.00205	CcSEcCtD
Budesonide—Malaise—Simvastatin—atherosclerosis	0.000927	0.00205	CcSEcCtD
Budesonide—Tension—Niacin—atherosclerosis	0.000926	0.00205	CcSEcCtD
Budesonide—Discomfort—Lovastatin—atherosclerosis	0.000924	0.00204	CcSEcCtD
Budesonide—Vertigo—Simvastatin—atherosclerosis	0.000923	0.00204	CcSEcCtD
Budesonide—Myalgia—Ezetimibe—atherosclerosis	0.000917	0.00203	CcSEcCtD
Budesonide—Chest pain—Ezetimibe—atherosclerosis	0.000917	0.00203	CcSEcCtD
Budesonide—Arthralgia—Ezetimibe—atherosclerosis	0.000917	0.00203	CcSEcCtD
Budesonide—Nervousness—Niacin—atherosclerosis	0.000917	0.00203	CcSEcCtD
Budesonide—Flatulence—Pravastatin—atherosclerosis	0.000916	0.00202	CcSEcCtD
Budesonide—Dry mouth—Lovastatin—atherosclerosis	0.000915	0.00202	CcSEcCtD
Budesonide—Tension—Pravastatin—atherosclerosis	0.000912	0.00201	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000911	0.00201	CcSEcCtD
Budesonide—Dysgeusia—Pravastatin—atherosclerosis	0.00091	0.00201	CcSEcCtD
Budesonide—Muscle spasms—Niacin—atherosclerosis	0.000907	0.002	CcSEcCtD
Budesonide—Discomfort—Ezetimibe—atherosclerosis	0.000907	0.002	CcSEcCtD
Budesonide—Constipation—Rosuvastatin—atherosclerosis	0.000905	0.002	CcSEcCtD
Budesonide—Pain—Rosuvastatin—atherosclerosis	0.000905	0.002	CcSEcCtD
Budesonide—Confusional state—Lovastatin—atherosclerosis	0.000904	0.002	CcSEcCtD
Budesonide—Nervousness—Pravastatin—atherosclerosis	0.000902	0.00199	CcSEcCtD
Budesonide—Dry mouth—Ezetimibe—atherosclerosis	0.000897	0.00198	CcSEcCtD
Budesonide—Anaphylactic shock—Lovastatin—atherosclerosis	0.000897	0.00198	CcSEcCtD
Budesonide—Muscle spasms—Pravastatin—atherosclerosis	0.000893	0.00197	CcSEcCtD
Budesonide—Infection—Lovastatin—atherosclerosis	0.000891	0.00197	CcSEcCtD
Budesonide—Vision blurred—Niacin—atherosclerosis	0.000889	0.00197	CcSEcCtD
Budesonide—NR3C1—Circadian Clock—NAMPT—atherosclerosis	0.000889	0.0162	CbGpPWpGaD
Budesonide—Confusional state—Ezetimibe—atherosclerosis	0.000887	0.00196	CcSEcCtD
Budesonide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00088	0.00194	CcSEcCtD
Budesonide—Vision blurred—Pravastatin—atherosclerosis	0.000876	0.00194	CcSEcCtD
Budesonide—Myalgia—Simvastatin—atherosclerosis	0.000875	0.00193	CcSEcCtD
Budesonide—Chest pain—Simvastatin—atherosclerosis	0.000875	0.00193	CcSEcCtD
Budesonide—Arthralgia—Simvastatin—atherosclerosis	0.000875	0.00193	CcSEcCtD
Budesonide—Infection—Ezetimibe—atherosclerosis	0.000874	0.00193	CcSEcCtD
Budesonide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000872	0.00193	CcSEcCtD
Budesonide—Anxiety—Simvastatin—atherosclerosis	0.000872	0.00193	CcSEcCtD
Budesonide—Tremor—Pravastatin—atherosclerosis	0.000871	0.00192	CcSEcCtD
Budesonide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000865	0.00191	CcSEcCtD
Budesonide—Discomfort—Simvastatin—atherosclerosis	0.000864	0.00191	CcSEcCtD
Budesonide—Nervous system disorder—Ezetimibe—atherosclerosis	0.000863	0.00191	CcSEcCtD
Budesonide—Angioedema—Niacin—atherosclerosis	0.000862	0.00191	CcSEcCtD
Budesonide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000862	0.00191	CcSEcCtD
Budesonide—Anaemia—Pravastatin—atherosclerosis	0.000859	0.0019	CcSEcCtD
Budesonide—Anorexia—Lovastatin—atherosclerosis	0.000855	0.00189	CcSEcCtD
Budesonide—Skin disorder—Ezetimibe—atherosclerosis	0.000854	0.00189	CcSEcCtD
Budesonide—Angioedema—Pravastatin—atherosclerosis	0.000849	0.00188	CcSEcCtD
Budesonide—Vertigo—Niacin—atherosclerosis	0.000848	0.00187	CcSEcCtD
Budesonide—Syncope—Niacin—atherosclerosis	0.000846	0.00187	CcSEcCtD
Budesonide—Confusional state—Simvastatin—atherosclerosis	0.000846	0.00187	CcSEcCtD
Budesonide—NR3C1—Circadian Clock—F7—atherosclerosis	0.000843	0.0154	CbGpPWpGaD
Budesonide—Urticaria—Rosuvastatin—atherosclerosis	0.000841	0.00186	CcSEcCtD
Budesonide—Anaphylactic shock—Simvastatin—atherosclerosis	0.000839	0.00185	CcSEcCtD
Budesonide—Malaise—Pravastatin—atherosclerosis	0.000838	0.00185	CcSEcCtD
Budesonide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000836	0.00185	CcSEcCtD
Budesonide—Vertigo—Pravastatin—atherosclerosis	0.000835	0.00184	CcSEcCtD
Budesonide—Palpitations—Niacin—atherosclerosis	0.000834	0.00184	CcSEcCtD
Budesonide—Infection—Simvastatin—atherosclerosis	0.000833	0.00184	CcSEcCtD
Budesonide—Loss of consciousness—Niacin—atherosclerosis	0.000829	0.00183	CcSEcCtD
Budesonide—Cough—Niacin—atherosclerosis	0.000823	0.00182	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—atherosclerosis	0.00082	0.015	CbGpPWpGaD
Budesonide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000817	0.00181	CcSEcCtD
Budesonide—Insomnia—Lovastatin—atherosclerosis	0.000811	0.00179	CcSEcCtD
Budesonide—Cough—Pravastatin—atherosclerosis	0.000811	0.00179	CcSEcCtD
Budesonide—Paraesthesia—Lovastatin—atherosclerosis	0.000805	0.00178	CcSEcCtD
Budesonide—Arthralgia—Niacin—atherosclerosis	0.000803	0.00178	CcSEcCtD
Budesonide—Myalgia—Niacin—atherosclerosis	0.000803	0.00178	CcSEcCtD
Budesonide—Hypertension—Pravastatin—atherosclerosis	0.000802	0.00177	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000801	0.00177	CcSEcCtD
Budesonide—Anorexia—Simvastatin—atherosclerosis	0.0008	0.00177	CcSEcCtD
Budesonide—Dyspnoea—Lovastatin—atherosclerosis	0.000799	0.00177	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000798	0.00176	CcSEcCtD
Budesonide—Insomnia—Ezetimibe—atherosclerosis	0.000796	0.00176	CcSEcCtD
Budesonide—Myalgia—Pravastatin—atherosclerosis	0.000791	0.00175	CcSEcCtD
Budesonide—Arthralgia—Pravastatin—atherosclerosis	0.000791	0.00175	CcSEcCtD
Budesonide—Chest pain—Pravastatin—atherosclerosis	0.000791	0.00175	CcSEcCtD
Budesonide—Paraesthesia—Ezetimibe—atherosclerosis	0.00079	0.00175	CcSEcCtD
Budesonide—Dyspepsia—Lovastatin—atherosclerosis	0.000789	0.00174	CcSEcCtD
Budesonide—Anxiety—Pravastatin—atherosclerosis	0.000788	0.00174	CcSEcCtD
Budesonide—Dry mouth—Niacin—atherosclerosis	0.000786	0.00174	CcSEcCtD
Budesonide—Dyspnoea—Ezetimibe—atherosclerosis	0.000784	0.00173	CcSEcCtD
Budesonide—Discomfort—Pravastatin—atherosclerosis	0.000782	0.00173	CcSEcCtD
Budesonide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00078	0.00172	CcSEcCtD
Budesonide—Decreased appetite—Lovastatin—atherosclerosis	0.00078	0.00172	CcSEcCtD
Budesonide—Dyspepsia—Ezetimibe—atherosclerosis	0.000774	0.00171	CcSEcCtD
Budesonide—Fatigue—Lovastatin—atherosclerosis	0.000773	0.00171	CcSEcCtD
Budesonide—Anaphylactic shock—Niacin—atherosclerosis	0.00077	0.0017	CcSEcCtD
Budesonide—Constipation—Lovastatin—atherosclerosis	0.000767	0.00169	CcSEcCtD
Budesonide—Pain—Lovastatin—atherosclerosis	0.000767	0.00169	CcSEcCtD
Budesonide—Confusional state—Pravastatin—atherosclerosis	0.000765	0.00169	CcSEcCtD
Budesonide—Decreased appetite—Ezetimibe—atherosclerosis	0.000765	0.00169	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000764	0.00169	CcSEcCtD
Budesonide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000759	0.00168	CcSEcCtD
Budesonide—Asthenia—Rosuvastatin—atherosclerosis	0.000759	0.00168	CcSEcCtD
Budesonide—Insomnia—Simvastatin—atherosclerosis	0.000759	0.00168	CcSEcCtD
Budesonide—Anaphylactic shock—Pravastatin—atherosclerosis	0.000758	0.00168	CcSEcCtD
Budesonide—Fatigue—Ezetimibe—atherosclerosis	0.000758	0.00168	CcSEcCtD
Budesonide—Shock—Niacin—atherosclerosis	0.000758	0.00167	CcSEcCtD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.000756	0.0138	CbGpPWpGaD
Budesonide—Infection—Pravastatin—atherosclerosis	0.000753	0.00166	CcSEcCtD
Budesonide—Paraesthesia—Simvastatin—atherosclerosis	0.000753	0.00166	CcSEcCtD
Budesonide—Pain—Ezetimibe—atherosclerosis	0.000752	0.00166	CcSEcCtD
Budesonide—Constipation—Ezetimibe—atherosclerosis	0.000752	0.00166	CcSEcCtD
Budesonide—Tachycardia—Niacin—atherosclerosis	0.000752	0.00166	CcSEcCtD
Budesonide—Pruritus—Rosuvastatin—atherosclerosis	0.000749	0.00165	CcSEcCtD
Budesonide—Skin disorder—Niacin—atherosclerosis	0.000748	0.00165	CcSEcCtD
Budesonide—Dyspnoea—Simvastatin—atherosclerosis	0.000748	0.00165	CcSEcCtD
Budesonide—Hyperhidrosis—Niacin—atherosclerosis	0.000745	0.00165	CcSEcCtD
Budesonide—Feeling abnormal—Lovastatin—atherosclerosis	0.000739	0.00163	CcSEcCtD
Budesonide—Dyspepsia—Simvastatin—atherosclerosis	0.000738	0.00163	CcSEcCtD
Budesonide—Anorexia—Niacin—atherosclerosis	0.000734	0.00162	CcSEcCtD
Budesonide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000733	0.00162	CcSEcCtD
Budesonide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000733	0.00162	CcSEcCtD
Budesonide—Decreased appetite—Simvastatin—atherosclerosis	0.000729	0.00161	CcSEcCtD
Budesonide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000725	0.0016	CcSEcCtD
Budesonide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000724	0.0016	CcSEcCtD
Budesonide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000724	0.0016	CcSEcCtD
Budesonide—Fatigue—Simvastatin—atherosclerosis	0.000723	0.0016	CcSEcCtD
Budesonide—Anorexia—Pravastatin—atherosclerosis	0.000723	0.0016	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—SELE—atherosclerosis	0.00072	0.0131	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000719	0.00159	CcSEcCtD
Budesonide—Pain—Simvastatin—atherosclerosis	0.000717	0.00159	CcSEcCtD
Budesonide—Constipation—Simvastatin—atherosclerosis	0.000717	0.00159	CcSEcCtD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000714	0.013	CbGpPWpGaD
Budesonide—Urticaria—Lovastatin—atherosclerosis	0.000712	0.00157	CcSEcCtD
Budesonide—Body temperature increased—Lovastatin—atherosclerosis	0.000709	0.00157	CcSEcCtD
Budesonide—Abdominal pain—Lovastatin—atherosclerosis	0.000709	0.00157	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000702	0.00155	CcSEcCtD
Budesonide—Dizziness—Rosuvastatin—atherosclerosis	0.0007	0.00155	CcSEcCtD
Budesonide—Urticaria—Ezetimibe—atherosclerosis	0.000699	0.00154	CcSEcCtD
Budesonide—Insomnia—Niacin—atherosclerosis	0.000697	0.00154	CcSEcCtD
Budesonide—Body temperature increased—Ezetimibe—atherosclerosis	0.000695	0.00154	CcSEcCtD
Budesonide—Abdominal pain—Ezetimibe—atherosclerosis	0.000695	0.00154	CcSEcCtD
Budesonide—Paraesthesia—Niacin—atherosclerosis	0.000692	0.00153	CcSEcCtD
Budesonide—Feeling abnormal—Simvastatin—atherosclerosis	0.000691	0.00153	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000691	0.00153	CcSEcCtD
Budesonide—Dyspnoea—Niacin—atherosclerosis	0.000687	0.00152	CcSEcCtD
Budesonide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000686	0.00152	CcSEcCtD
Budesonide—Insomnia—Pravastatin—atherosclerosis	0.000686	0.00152	CcSEcCtD
Budesonide—Somnolence—Niacin—atherosclerosis	0.000685	0.00151	CcSEcCtD
Budesonide—Paraesthesia—Pravastatin—atherosclerosis	0.000681	0.0015	CcSEcCtD
Budesonide—Dyspepsia—Niacin—atherosclerosis	0.000678	0.0015	CcSEcCtD
Budesonide—Dyspnoea—Pravastatin—atherosclerosis	0.000676	0.00149	CcSEcCtD
Budesonide—Decreased appetite—Niacin—atherosclerosis	0.00067	0.00148	CcSEcCtD
Budesonide—Dyspepsia—Pravastatin—atherosclerosis	0.000668	0.00148	CcSEcCtD
Budesonide—Rash—Rosuvastatin—atherosclerosis	0.000667	0.00147	CcSEcCtD
Budesonide—Dermatitis—Rosuvastatin—atherosclerosis	0.000667	0.00147	CcSEcCtD
Budesonide—Urticaria—Simvastatin—atherosclerosis	0.000666	0.00147	CcSEcCtD
Budesonide—Dexamethasone—NOS2—atherosclerosis	0.000666	0.112	CrCbGaD
Budesonide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000665	0.00147	CcSEcCtD
Budesonide—Body temperature increased—Simvastatin—atherosclerosis	0.000663	0.00147	CcSEcCtD
Budesonide—Abdominal pain—Simvastatin—atherosclerosis	0.000663	0.00147	CcSEcCtD
Budesonide—Headache—Rosuvastatin—atherosclerosis	0.000663	0.00146	CcSEcCtD
Budesonide—Hypersensitivity—Lovastatin—atherosclerosis	0.000661	0.00146	CcSEcCtD
Budesonide—Decreased appetite—Pravastatin—atherosclerosis	0.000659	0.00146	CcSEcCtD
Budesonide—Pain—Niacin—atherosclerosis	0.000659	0.00146	CcSEcCtD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atherosclerosis	0.000654	0.0119	CbGpPWpGaD
Budesonide—Fatigue—Pravastatin—atherosclerosis	0.000654	0.00144	CcSEcCtD
Budesonide—Pain—Pravastatin—atherosclerosis	0.000648	0.00143	CcSEcCtD
Budesonide—Constipation—Pravastatin—atherosclerosis	0.000648	0.00143	CcSEcCtD
Budesonide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000648	0.00143	CcSEcCtD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000647	0.0118	CbGpPWpGaD
Budesonide—Asthenia—Lovastatin—atherosclerosis	0.000643	0.00142	CcSEcCtD
Budesonide—NR3C1—Nuclear Receptors—PPARA—atherosclerosis	0.00064	0.0117	CbGpPWpGaD
Budesonide—Pruritus—Lovastatin—atherosclerosis	0.000634	0.0014	CcSEcCtD
Budesonide—Asthenia—Ezetimibe—atherosclerosis	0.000631	0.00139	CcSEcCtD
Budesonide—Gastrointestinal pain—Niacin—atherosclerosis	0.00063	0.00139	CcSEcCtD
Budesonide—Nausea—Rosuvastatin—atherosclerosis	0.000629	0.00139	CcSEcCtD
Budesonide—Feeling abnormal—Pravastatin—atherosclerosis	0.000625	0.00138	CcSEcCtD
Budesonide—Pruritus—Ezetimibe—atherosclerosis	0.000622	0.00138	CcSEcCtD
Budesonide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00062	0.00137	CcSEcCtD
Budesonide—Hypersensitivity—Simvastatin—atherosclerosis	0.000618	0.00137	CcSEcCtD
Budesonide—Diarrhoea—Lovastatin—atherosclerosis	0.000614	0.00136	CcSEcCtD
Budesonide—Urticaria—Niacin—atherosclerosis	0.000612	0.00135	CcSEcCtD
Budesonide—Abdominal pain—Niacin—atherosclerosis	0.000609	0.00135	CcSEcCtD
Budesonide—Body temperature increased—Niacin—atherosclerosis	0.000609	0.00135	CcSEcCtD
Budesonide—Urticaria—Pravastatin—atherosclerosis	0.000602	0.00133	CcSEcCtD
Budesonide—Asthenia—Simvastatin—atherosclerosis	0.000602	0.00133	CcSEcCtD
Budesonide—Diarrhoea—Ezetimibe—atherosclerosis	0.000602	0.00133	CcSEcCtD
Budesonide—Abdominal pain—Pravastatin—atherosclerosis	0.000599	0.00132	CcSEcCtD
Budesonide—Body temperature increased—Pravastatin—atherosclerosis	0.000599	0.00132	CcSEcCtD
Budesonide—Pruritus—Simvastatin—atherosclerosis	0.000593	0.00131	CcSEcCtD
Budesonide—Dizziness—Lovastatin—atherosclerosis	0.000593	0.00131	CcSEcCtD
Budesonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.00059	0.0108	CbGpPWpGaD
Budesonide—Dizziness—Ezetimibe—atherosclerosis	0.000582	0.00129	CcSEcCtD
Budesonide—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.00058	0.0106	CbGpPWpGaD
Budesonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.00058	0.0106	CbGpPWpGaD
Budesonide—Diarrhoea—Simvastatin—atherosclerosis	0.000574	0.00127	CcSEcCtD
Budesonide—Vomiting—Lovastatin—atherosclerosis	0.00057	0.00126	CcSEcCtD
Budesonide—Hypersensitivity—Niacin—atherosclerosis	0.000567	0.00125	CcSEcCtD
Budesonide—Rash—Lovastatin—atherosclerosis	0.000565	0.00125	CcSEcCtD
Budesonide—Dermatitis—Lovastatin—atherosclerosis	0.000565	0.00125	CcSEcCtD
Budesonide—Headache—Lovastatin—atherosclerosis	0.000562	0.00124	CcSEcCtD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.00056	0.0102	CbGpPWpGaD
Budesonide—Vomiting—Ezetimibe—atherosclerosis	0.000559	0.00124	CcSEcCtD
Budesonide—Hypersensitivity—Pravastatin—atherosclerosis	0.000559	0.00123	CcSEcCtD
Budesonide—Dizziness—Simvastatin—atherosclerosis	0.000555	0.00123	CcSEcCtD
Budesonide—Rash—Ezetimibe—atherosclerosis	0.000555	0.00123	CcSEcCtD
Budesonide—Dermatitis—Ezetimibe—atherosclerosis	0.000554	0.00122	CcSEcCtD
Budesonide—Asthenia—Niacin—atherosclerosis	0.000553	0.00122	CcSEcCtD
Budesonide—Headache—Ezetimibe—atherosclerosis	0.000551	0.00122	CcSEcCtD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.00055	0.01	CbGpPWpGaD
Budesonide—Pruritus—Niacin—atherosclerosis	0.000545	0.0012	CcSEcCtD
Budesonide—Asthenia—Pravastatin—atherosclerosis	0.000544	0.0012	CcSEcCtD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.00054	0.00986	CbGpPWpGaD
Budesonide—Pruritus—Pravastatin—atherosclerosis	0.000537	0.00119	CcSEcCtD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000534	0.00975	CbGpPWpGaD
Budesonide—Vomiting—Simvastatin—atherosclerosis	0.000533	0.00118	CcSEcCtD
Budesonide—Nausea—Lovastatin—atherosclerosis	0.000533	0.00118	CcSEcCtD
Budesonide—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.000529	0.00966	CbGpPWpGaD
Budesonide—Rash—Simvastatin—atherosclerosis	0.000529	0.00117	CcSEcCtD
Budesonide—Dermatitis—Simvastatin—atherosclerosis	0.000528	0.00117	CcSEcCtD
Budesonide—Diarrhoea—Niacin—atherosclerosis	0.000527	0.00116	CcSEcCtD
Budesonide—Headache—Simvastatin—atherosclerosis	0.000525	0.00116	CcSEcCtD
Budesonide—Nausea—Ezetimibe—atherosclerosis	0.000522	0.00115	CcSEcCtD
Budesonide—Diarrhoea—Pravastatin—atherosclerosis	0.000519	0.00115	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—AHR—atherosclerosis	0.000511	0.00933	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.00051	0.0093	CbGpPWpGaD
Budesonide—Dizziness—Niacin—atherosclerosis	0.000509	0.00113	CcSEcCtD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.000506	0.00924	CbGpPWpGaD
Budesonide—Dizziness—Pravastatin—atherosclerosis	0.000501	0.00111	CcSEcCtD
Budesonide—Nausea—Simvastatin—atherosclerosis	0.000498	0.0011	CcSEcCtD
Budesonide—Vomiting—Niacin—atherosclerosis	0.00049	0.00108	CcSEcCtD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.000487	0.00889	CbGpPWpGaD
Budesonide—Rash—Niacin—atherosclerosis	0.000486	0.00107	CcSEcCtD
Budesonide—Dermatitis—Niacin—atherosclerosis	0.000485	0.00107	CcSEcCtD
Budesonide—Headache—Niacin—atherosclerosis	0.000482	0.00107	CcSEcCtD
Budesonide—Vomiting—Pravastatin—atherosclerosis	0.000482	0.00107	CcSEcCtD
Budesonide—Rash—Pravastatin—atherosclerosis	0.000478	0.00106	CcSEcCtD
Budesonide—Dermatitis—Pravastatin—atherosclerosis	0.000478	0.00106	CcSEcCtD
Budesonide—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.000476	0.0087	CbGpPWpGaD
Budesonide—Headache—Pravastatin—atherosclerosis	0.000475	0.00105	CcSEcCtD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000462	0.00843	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.000458	0.00837	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.000458	0.00837	CbGpPWpGaD
Budesonide—Nausea—Niacin—atherosclerosis	0.000457	0.00101	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.000454	0.00829	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.000453	0.00827	CbGpPWpGaD
Budesonide—Nausea—Pravastatin—atherosclerosis	0.00045	0.000995	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.000447	0.00816	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000444	0.00811	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.000435	0.00794	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.000423	0.00773	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.000418	0.00763	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000411	0.0075	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000405	0.0074	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.000403	0.00736	CbGpPWpGaD
Budesonide—Triamcinolone—PTGS2—atherosclerosis	0.000401	0.0672	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.000385	0.00703	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.00038	0.00694	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.00038	0.00693	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000375	0.00684	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.000366	0.00667	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.000356	0.0065	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.000355	0.00647	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.000351	0.00641	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.000339	0.0062	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000334	0.0061	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000333	0.00608	CbGpPWpGaD
Budesonide—Betamethasone—PTGS2—atherosclerosis	0.000329	0.0551	CrCbGaD
Budesonide—Prednisone—ALB—atherosclerosis	0.000324	0.0543	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.000317	0.00578	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.000313	0.00572	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.000309	0.00564	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.000308	0.00563	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000308	0.00562	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.000304	0.00555	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.000272	0.00497	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—LPL—atherosclerosis	0.000271	0.00495	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000266	0.00486	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.00026	0.00475	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000248	0.00452	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.000239	0.00437	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000239	0.00436	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000235	0.00428	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—AGT—atherosclerosis	0.000232	0.00423	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000232	0.00423	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000227	0.00415	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000224	0.00409	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000218	0.00398	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.000198	0.00361	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000195	0.00356	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—INS—atherosclerosis	0.000194	0.00354	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000192	0.0035	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000191	0.0035	CbGpPWpGaD
Budesonide—Dexamethasone—PTGS2—atherosclerosis	0.000191	0.032	CrCbGaD
Budesonide—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000189	0.00345	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.000188	0.00343	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000186	0.0034	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000185	0.00337	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.000178	0.00325	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000177	0.00323	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000174	0.00318	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.000168	0.00306	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000164	0.00298	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000161	0.00294	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000139	0.00254	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000138	0.00252	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	0.000131	0.00238	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.00013	0.00238	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000125	0.00228	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	0.000123	0.00224	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—STAT3—atherosclerosis	0.000121	0.00222	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000117	0.00213	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000114	0.00208	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	0.000113	0.00206	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TGFB1—atherosclerosis	0.000113	0.00205	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000106	0.00193	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TNF—atherosclerosis	0.000105	0.00192	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	9.08e-05	0.00166	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	8.74e-05	0.0016	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IL6—atherosclerosis	8.48e-05	0.00155	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	7.92e-05	0.00145	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HSPA1B—atherosclerosis	7.45e-05	0.00136	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	7.33e-05	0.00134	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	7.3e-05	0.00133	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	7.22e-05	0.00132	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	7.2e-05	0.00131	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PARP1—atherosclerosis	6.64e-05	0.00121	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	6.51e-05	0.00119	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESR2—atherosclerosis	6.29e-05	0.00115	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	5.18e-05	0.000945	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SIRT1—atherosclerosis	5.06e-05	0.000924	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLTP—atherosclerosis	4.87e-05	0.000889	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCG8—atherosclerosis	4.22e-05	0.000771	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LTA4H—atherosclerosis	4.22e-05	0.000771	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARA—atherosclerosis	4.21e-05	0.000768	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESR1—atherosclerosis	3.81e-05	0.000696	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARG—atherosclerosis	3.48e-05	0.000635	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCG1—atherosclerosis	3.34e-05	0.000609	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FABP4—atherosclerosis	3.14e-05	0.000573	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LCAT—atherosclerosis	3.14e-05	0.000573	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SERPINE1—atherosclerosis	3.13e-05	0.000572	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOA4—atherosclerosis	3.08e-05	0.000562	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.03e-05	0.000552	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	2.8e-05	0.00051	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOA2—atherosclerosis	2.65e-05	0.000484	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	2.65e-05	0.000484	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	2.65e-05	0.000484	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALOX15—atherosclerosis	2.65e-05	0.000484	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCG5—atherosclerosis	2.62e-05	0.000478	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LPA—atherosclerosis	2.53e-05	0.000462	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—BGN—atherosclerosis	2.45e-05	0.000447	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOA5—atherosclerosis	2.42e-05	0.000443	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.33e-05	0.000426	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.25e-05	0.000411	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MAPK3—atherosclerosis	2.04e-05	0.000372	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.02e-05	0.000369	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LIPC—atherosclerosis	2.01e-05	0.000367	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOC3—atherosclerosis	2e-05	0.000364	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LDLR—atherosclerosis	1.98e-05	0.000362	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CETP—atherosclerosis	1.94e-05	0.000354	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.86e-05	0.000339	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.75e-05	0.00032	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.56e-05	0.000285	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AKT1—atherosclerosis	1.38e-05	0.000251	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.34e-05	0.000245	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOB—atherosclerosis	1.28e-05	0.000234	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.25e-05	0.000228	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LPL—atherosclerosis	1.23e-05	0.000224	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPX1—atherosclerosis	1.2e-05	0.000218	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CD36—atherosclerosis	1.16e-05	0.000213	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.1e-05	0.000202	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARA—atherosclerosis	1.08e-05	0.000198	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AGT—atherosclerosis	1.05e-05	0.000191	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOE—atherosclerosis	1.03e-05	0.000188	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CAV1—atherosclerosis	1.02e-05	0.000186	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOA1—atherosclerosis	1.02e-05	0.000185	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	9.28e-06	0.000169	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARG—atherosclerosis	8.95e-06	0.000163	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—INS—atherosclerosis	8.78e-06	0.00016	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALB—atherosclerosis	8.05e-06	0.000147	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NOS3—atherosclerosis	7.7e-06	0.000141	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS2—atherosclerosis	7.04e-06	0.000129	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKT1—atherosclerosis	3.54e-06	6.46e-05	CbGpPWpGaD
